Symbol: |
ELOVL4
|
Description: |
ELOVL fatty acid elongase 4 [Source:HGNC Symbol;Acc:14415]
|
Location: |
Chr6:80624529-80657297[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:169
Gene |
Compound |
Gen_sig |
Exp_pattern |
ELOVL4 |
11H-Indeno[1,2-c]isoquinolinium, 9-hydroxy-2,3,8-trimethoxy-6-methyl-, chloride |
0.004 |
Down |
ELOVL4 |
Piperidine, 2,6-diphenyl-1-methyl-4-[(phenylmethoxy)imino]-, cis- |
0.007 |
Down |
ELOVL4 |
ANTINEOPLASTIC-376265 |
0.03 |
Down |
ELOVL4 |
PHYTOENE |
0.022 |
Down |
ELOVL4 |
FCDR |
0.015 |
Down |
ELOVL4 |
NSC 49713 |
0.012 |
Down |
ELOVL4 |
NSC 527353 |
0.049 |
Up |
ELOVL4 |
NSC 58903 |
0.015 |
Down |
ELOVL4 |
9-AC |
0.018 |
Down |
ELOVL4 |
Camptothecin ethylglycinate ester hydrochloride |
0.008 |
Down |
ELOVL4 |
Camptothecin hemisuccinate sodium salt |
0.002 |
Down |
ELOVL4 |
Camptothecin lysinate HCl |
0.01 |
Down |
ELOVL4 |
4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride |
0.028 |
Down |
ELOVL4 |
14-FLUORO-4-DEMETHOXYDAUNORUBICIN |
0.028 |
Down |
ELOVL4 |
ANTINEOPLASTIC-625543 |
0.021 |
Down |
Expression pattern: Sensitivity / Resistance
Total:12 Current:3
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:30
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:6
Gene |
Gen_transcript |
miRNA |
miR_location |
ELOVL4 |
ENST00000369816 |
hsa-mir-155-3p |
Chr21:26946334-26946355[+] |
ELOVL4 |
ENST00000369816 |
hsa-mir-16-5p |
Chr13:50623163-50623184[-] |
ELOVL4 |
ENST00000369816 |
hsa-mir-16-5p |
Chr3:160122542-160122563[+] |
ELOVL4 |
ENST00000369816 |
hsa-mir-224-5p |
ChrX:151127103-151127123[-] |
ELOVL4 |
ENST00000369816 |
hsa-mir-29a-5p |
Chr7:130561545-130561566[-] |
ELOVL4 |
ENST00000369816 |
hsa-mir-29c-5p |
Chr1:207975248-207975269[-] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|